A cross-sectional descriptive survey of the BOLD for individuals after having been ill
with COVID-19 or have taken the COVID-19 vaccine will be compared with that of
individuals who have neither been ill with COVID-19 nor taken the COVID-19 vaccine.
Individuals who have both been ill and taken the COVID-19 vaccine will be compared to
identify any additive risk factors.

The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

COVID-19

Lyme Disease

COVID-19 Vaccine

Primary research question:

  1. Will the BOLD be worse for individuals who have taken the COVID-19 vaccine?

Secondary research questions:

  1. Will the BOLD be worse for individuals who have been ill with COVID-19?

  2. What factors affect the BOLD in individuals a) after having been ill with COVID-19,
     and b) in those who have taken the COVID-19 vaccine? Do they differ?

  3. If BOLD risk factors specific to either the COVID-19 vaccine or having been ill with
     COVID-19 are found, are they additive in people who have experienced both?

  4. What is the prevalence of hesitancy in the Lyme disease community to the COVID-19
     vaccine?

  5. What is the severity of symptoms most likely to predict functional problems in
     individuals with Lyme disease who have been ill with COVID-19 or taken the COVID-19
     vaccine?

The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort Survey

About this trial

Study ID

Status

Type

Placebo

Accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status